Skip Navigation

JNCI Journal of the National Cancer Institute 2009 101(21):1435; doi:10.1093/jnci/djp389
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2009.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Cancer Incidence in Israeli Jewish Survivors of World War II

Israeli Jews of European origin, many of whom were exposed to severe famine and stress during World War II, have been found to have high incidence rates of all cancers. Keinan-Boker et al. (p. 1489) assembled a cohort of European-born Israeli Jews to investigate whether exposure to the Holocaust was associated with risk for cancer. Because individual data were not available, they used the immigration date for each individual to determine exposure. They found that, among all birth cohorts and among both sexes, exposure was associated with a statistically significantly higher risk for cancer than nonexposure. This was true for cancer at all . . . [Full Text of this Article]

Methods for Biomarker Studies with Archived Specimens

Workshop on Biomarker and Drug Co-Development

Serum Müllerian Inhibiting Substance and Breast Cancer

Merkel Cell Polyomavirus and Merkel Cell Carcinoma

Instruments for Screening for Emotional Distress in Cancer Patients


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Cancer Incidence in Israeli Jewish Survivors of World War II
Lital Keinan-Boker, Neomi Vin-Raviv, Irena Liphshitz, Shai Linn, and Micha Barchana
J Natl Cancer Inst 2009 101: 1489-1500. [Abstract] [Full Text] [PDF]

Prospective Case–Control Study of Serum Müllerian Inhibiting Substance and Breast Cancer Risk
Joanne F. Dorgan, Frank Z. Stanczyk, Brian L. Egleston, Lisa L. Kahle, Christiana M. Shaw, Cynthia S. Spittle, Andrew K. Godwin, and Louise A. Brinton
J Natl Cancer Inst 2009 101: 1501-1509. [Abstract] [Full Text] [PDF]

Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma
Joseph J. Carter, Kelly G. Paulson, Greg C. Wipf, Danielle Miranda, Margaret M. Madeleine, Lisa G. Johnson, Bianca D. Lemos, Sherry Lee, Ashley H. Warcola, Jayasri G. Iyer, Paul Nghiem, and Denise A. Galloway
J Natl Cancer Inst 2009 101: 1510-1522. [Abstract] [Full Text] [PDF]

A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment
Sheila E. Taube, Gary M. Clark, Janet E. Dancey, Lisa M. McShane, Caroline C. Sigman, and Steven I. Gutman
J Natl Cancer Inst 2009 101: 1453-1463. [Abstract] [Full Text] [PDF]

Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
Richard M. Simon, Soonmyung Paik, and Daniel F. Hayes
J Natl Cancer Inst 2009 101: 1446-1452. [Abstract] [Full Text] [PDF]

Screening for Emotional Distress in Cancer Patients: A Systematic Review of Assessment Instruments
Andrea Vodermaier, Wolfgang Linden, and Christopher Siu
J Natl Cancer Inst 2009 101: 1464-1488. [Abstract] [Full Text] [PDF]

Cancer Risk From Extreme Stressors: Lessons From European Jewish Survivors of World War II
Stephen D. Hursting and Michele R. Forman
J Natl Cancer Inst 2009 101: 1436-1437. [Extract] [Full Text] [PDF]